Research & Innovation
Publications

A chemogenomic screening identifies CK2 as a target for pro-senescence therapy in PTEN-deficient tumours.

#2015

#Nature Communications

PMU Author
Ravi Kalathur

All Authors
Madhuri Kalathur, Alberto Toso, Jingjing Chen, Ajinkya Revandkar, Claudia Danzer-Baltzer, Ilaria Guccini, Abdullah Alajati, Manuela Sarti, Sandra Pinton, Lara Brambilla, Diletta Di Mitri, Giuseppina Carbone, R. Garcia-Escudero, Alessandro Padova, Letizia Magnoni, Alessia Tarditi, Laura Maccari, Federico Malusa, Ravi Kalathur, Lorenzo A Pinna, Giorgio Cozza, Maria Ruzzene, Nicolas Delaleu, Carlo V Catapano, Ian J Frew, Andrea Alimonti

Journal association
Nature Communications

Abstract

Keywords

EXPRESSION, PROSTATE-CANCER, EFFICACY, SURVEILLANCE, INHIBITOR, SUPPRESSOR, PROTEIN-KINASE CK2, CELL-CYCLE ARREST, PML, POTENT

Latest Publication

#2026

#Original Article

Mathias Ausserwinkler, Axel J. Hueber, Sophie Gensluckner, Bernhard Paulweber, Eugen Trinka, Patrick Langthaler, Bernhard Iglseder, Maria Flamm, Elmar Aigner, Bernhard Wernly Association between rheumatoid arthritis and depressive symptoms, INFLAMMATION; DEPRESSION; Rheumatoid arthritis; Mental Health; Population-based study; Somatic comorbidity;

#2026

#Original Article

Noel Spoelder, Tom D. Turmezei, Dimitri A. Kessler, James W. Mackay, Simon C. Mastbergen, Marcel Karperien, Mylene P. Jansen, Felix Eckstein Sex-related differences in femorotibial cartilage thickness, OSTEOARTHRITIS; KNEE; CARTILAGE THICKNESS; 3d mri; Sex-related differences;

#2026

#Editorial

Bram Tilburgs, Heidi Lindroth, Peter Nydahl Virtual reality in ICU delirium care, UNIT;

Back to Overview

Paracelsus Medical Private University (PMU) Research & Innovation Publications

A chemogenomic screening identifies CK2 as a...